Direct Intrahepatic Portocaval Shunt for Sinusoidal Obstruction Syndrome Associated with Hepatotoxicity of Pyrrolizidine Alkaloids

Table 2

Treatment outcomes in two groups.

Outcomes/groups	A		value	B		value
	Before	After		Before	After
				15.31±3.13	16.41±6.10	0.248
IVC (mmHg)	17.07±3.93	3.83±3.71	≤0.001	16.41±3.79	4.15±3.79	0.001(0.018)
PSG (mmHg)	44.97±11.87	24.88±5.28	≤0.001	45.88±9.05	24.13±3.91	0.001(0.604)